Updates of incretin‐related drugs for the treatment of type 2 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Updates of incretin‐related drugs for the treatment of type 2 diabetes

Published:2022-11-14 Issue:2 Volume:14 Page:189-192
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J of Diabetes Invest

Author:

Araki Hirotaka¹²,Matsumura Takeshi¹,Furukawa Noboru¹³,Araki Eiichi¹^ORCID

Affiliation:

1. Department of Metabolic Medicine, Faculty of Life Sciences Kumamoto University Kumamoto Japan

2. Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics Kumamoto University Kumamoto Japan

3. Center for Medical Education and Research, Faculty of Life Sciences Kumamoto University Kumamoto Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13945

Reference23 articles.

1. Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61)

2. Retrospective nationwide study on the trends in first‐line antidiabetic medication for patients with type 2 diabetes in Japan

3. Glucose‐lowering action through targeting islet dysfunction in type 2 diabetes: Focus on dipeptidyl peptidase‐4 inhibition

4. Incretin physiology and pathophysiology from an A sian perspective

5. Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vital role of CYP450 in the biodegradation of antidiabetic drugs in the aerobic activated sludge system and the mechanisms;Journal of Hazardous Materials;2024-05

2. From classical dualistic antagonism to hormone synergy: potential of overlapping action of glucagon, insulin and GLP-1 for the treatment of diabesity;Endocrine Connections;2024-04-03

3. The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance;Journal of Diabetes and its Complications;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3